Published in Nucleic Acids Res on March 11, 1991
An analysis of vertebrate mRNA sequences: intimations of translational control. J Cell Biol (1991) 12.00
Murine helix-loop-helix transcriptional activator proteins binding to the E-box motif of the Akv murine leukemia virus enhancer identified by cDNA cloning. Mol Cell Biol (1992) 1.16
TFEC, a basic helix-loop-helix protein, forms heterodimers with TFE3 and inhibits TFE3-dependent transcription activation. Mol Cell Biol (1993) 1.16
The DNA-binding protein E12 co-operates with XMyoD in the activation of muscle-specific gene expression in Xenopus embryos. EMBO J (1992) 0.98
Inhibition of thyrotropin-stimulated DNA synthesis by microinjection of inhibitors of cellular Ras and cyclic AMP-dependent protein kinase. Mol Cell Biol (1993) 0.94
Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell (1986) 42.45
A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Res (1988) 26.70
A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell (1989) 21.54
Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science (1986) 15.84
Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell (1989) 14.24
Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell (1989) 11.41
A simple phase-extraction assay for chloramphenicol acyltransferase activity. Gene (1988) 8.40
Molecular cloning of an enhancer binding protein: isolation by screening of an expression library with a recognition site DNA. Cell (1988) 8.00
The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation. Cell (1990) 7.94
Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP. Cell (1987) 7.75
In situ detection of sequence-specific DNA binding activity specified by a recombinant bacteriophage. Genes Dev (1988) 6.97
Two distinct transcription factors that bind the immunoglobulin enhancer microE5/kappa 2 motif. Science (1990) 4.93
Yeast centromere binding protein CBF1, of the helix-loop-helix protein family, is required for chromosome stability and methionine prototrophy. Cell (1990) 4.59
Cyclic AMP and the induction of eukaryotic gene transcription. J Biol Chem (1988) 4.58
Transcriptional regulation by dimerization: two sides to an incestuous relationship. Cell (1990) 3.59
A helix-loop-helix protein related to the immunoglobulin E box-binding proteins. Mol Cell Biol (1990) 2.90
A thyroid-specific nuclear protein essential for tissue-specific expression of the thyroglobulin promoter. EMBO J (1989) 2.21
cAMP-dependent binding of a trans-acting factor to the thyroglobulin promoter. Biochem Biophys Res Commun (1989) 1.67
Control of thyroglobulin synthesis and secretion (second of two parts). N Engl J Med (1979) 1.41
A cell type specific factor recognizes the rat thyroglobulin promoter. Nucleic Acids Res (1987) 1.27
Thyrotropin controls transcription of the thyroglobulin gene. Proc Natl Acad Sci U S A (1984) 1.24
Control of thyroperoxidase and thyroglobulin transcription by cAMP: evidence for distinct regulatory mechanisms. Mol Endocrinol (1989) 1.02
Identification of a cAMP-responsive region in thyroglobulin gene promoter. Mol Cell Endocrinol (1989) 0.99
Cloning and sequencing of a calcium-binding protein regulated by cyclic AMP in the thyroid. EMBO J (1989) 0.95
Transcriptional control of thyroglobulin gene expression by cyclic AMP. FEBS Lett (1985) 0.82
Gene regulation. More to muscle than MyoD. Nature (1990) 0.78
Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature (1996) 15.91
A sequence in M13 phage detects hypervariable minisatellites in human and animal DNA. Science (1987) 7.20
Selective amplification and cloning of four new members of the G protein-coupled receptor family. Science (1989) 6.67
The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem (2001) 4.77
Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry (1996) 4.35
Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science (1999) 4.31
ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett (1994) 3.78
Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature (1997) 3.75
Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell (1996) 3.44
Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature (1993) 3.19
Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J Biol Chem (2000) 2.70
Molecular cloning of the thyrotropin receptor. Science (1989) 2.32
Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem J (1991) 2.23
Presentation of the same glycolipid by different CD1 molecules. J Exp Med (2002) 2.06
Primary structure of bovine thyroglobulin deduced from the sequence of its 8,431-base complementary DNA. Nature (1985) 1.96
RDC8 codes for an adenosine A2 receptor with physiological constitutive activity. Biochem Biophys Res Commun (1990) 1.94
Self glycolipids as T-cell autoantigens. Eur J Immunol (1999) 1.93
ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains. Eur J Immunol (1998) 1.88
CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist. Blood (1999) 1.75
The alphabeta T cell response to self-glycolipids shows a novel mechanism of CD1b loading and a requirement for complex oligosaccharides. Immunity (2000) 1.72
Human 27-kDa calbindin complementary DNA sequence. Evolutionary and functional implications. Eur J Biochem (1987) 1.68
cAMP-dependent binding of a trans-acting factor to the thyroglobulin promoter. Biochem Biophys Res Commun (1989) 1.67
The deltaccr5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in Northeastern Europe. Hum Mol Genet (1998) 1.67
Presence of nonfunctional thyrotropin receptor variant transcripts in retroocular and other tissues. J Clin Endocrinol Metab (1994) 1.65
Tyrosine sulfation is required for agonist recognition by glycoprotein hormone receptors. EMBO J (2002) 1.64
The second extracellular loop of CCR5 is the major determinant of ligand specificity. J Biol Chem (1997) 1.62
The orphan receptor cDNA RDC7 encodes an A1 adenosine receptor. EMBO J (1991) 1.57
Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: evidence for binding of autoantibodies. Biochem Biophys Res Commun (1989) 1.57
Modeling of the three-dimensional structure of proteins with the typical leucine-rich repeats. Structure (1995) 1.55
Failure of membrane targeting causes the functional defect of two mutant sodium iodide symporters. J Clin Endocrinol Metab (2000) 1.54
An unusually long poly(purine)-poly(pyrimidine) sequence is located upstream from the human thyroglobulin gene. Nucleic Acids Res (1985) 1.53
A germline mutation of the thyrotropin receptor gene associated with thyrotoxicosis and mitral valve prolapse in a Chinese family. J Clin Endocrinol Metab (1999) 1.51
DNA fingerprinting in domestic animals using four different minisatellite probes. Cytogenet Cell Genet (1988) 1.50
Resistance to thyrotropin (TSH) in three families is not associated with mutations in the TSH receptor or TSH. J Clin Endocrinol Metab (1997) 1.44
Triiodothyronine stimulates specifically growth hormone mRNA in rat pituitary tumor cells. Proc Natl Acad Sci U S A (1977) 1.43
Control of thyroglobulin synthesis and secretion (second of two parts). N Engl J Med (1979) 1.41
Brief report: congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene. N Engl J Med (1995) 1.41
Genetic immunization against the human thyrotropin receptor causes thyroiditis and allows production of monoclonal antibodies recognizing the native receptor. J Immunol (1998) 1.38
Manic-depression locus on X chromosome. Lancet (1991) 1.38
The TXP motif in the second transmembrane helix of CCR5. A structural determinant of chemokine-induced activation. J Biol Chem (2001) 1.37
Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 Env protein. J Biol Chem (1999) 1.36
Extracellular cysteines of CCR5 are required for chemokine binding, but dispensable for HIV-1 coreceptor activity. J Biol Chem (1999) 1.34
Presence and absence of follicle-stimulating hormone receptor mutations provide some insights into spontaneous ovarian hyperstimulation syndrome physiopathology. J Clin Endocrinol Metab (2005) 1.33
Translational control of protein synthesis: a simulation study. Biochim Biophys Acta (1971) 1.32
Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves' disease. J Clin Invest (2000) 1.31
Cloning of human thyroglobulin complementary DNA. FEBS Lett (1982) 1.29
A conserved Asn in transmembrane helix 7 is an on/off switch in the activation of the thyrotropin receptor. J Biol Chem (2001) 1.29
Specific repertoire of olfactory receptor genes in the male germ cells of several mammalian species. Genomics (1997) 1.27
Stable expression of the human TSH receptor in CHO cells and characterization of differentially expressing clones. Biochem Biophys Res Commun (1990) 1.27
A nonsense mutation causes hereditary goitre in the Afrikander cattle and unmasks alternative splicing of thyroglobulin transcripts. Proc Natl Acad Sci U S A (1987) 1.26
Thyrotropin controls transcription of the thyroglobulin gene. Proc Natl Acad Sci U S A (1984) 1.24
Palmitoylation of CCR5 is critical for receptor trafficking and efficient activation of intracellular signaling pathways. J Biol Chem (2001) 1.24
Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. N Engl J Med (1998) 1.24
Synthesis of a full length DNA complementary to thyroglobulin 33 S messenger RNA. Biochem Biophys Res Commun (1980) 1.21
Polymorphic DNA marker on X chromosome and manic depression. Lancet (1987) 1.21
Control of thyroglobulin synthesis and secretion. (First of two parts). N Engl J Med (1979) 1.18
Molecular cloning, functional expression and pharmacological characterization of a human bradykinin B2 receptor gene. Biochem Biophys Res Commun (1992) 1.17
Analysis of sequence and structure homologies between thyroglobulin and acetylcholinesterase: possible functional and clinical significance. Biochem Biophys Res Commun (1986) 1.16
Multiple nonfunctional alleles of CCR5 are frequent in various human populations. Blood (2000) 1.16
The human thyroglobulin gene contains two 15-17 kb introns near its 3'-end. Nucleic Acids Res (1983) 1.15
Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. J Clin Endocrinol Metab (1999) 1.15
Molecular cloning of an orphan G-protein-coupled receptor that constitutively activates adenylate cyclase. Biochem J (1995) 1.14
Complete nucleotide sequence of a putative G protein coupled receptor: RDC1. Nucleic Acids Res (1990) 1.14
Identification of polysomes synthesizing thyroglobulin. Eur J Biochem (1973) 1.14
Identification of a mutation in the coding sequence of the human thyroid peroxidase gene causing congenital goiter. J Clin Invest (1992) 1.12
The genes encoding the human CC-chemokine receptors CC-CKR1 to CC-CKR5 (CMKBR1-CMKBR5) are clustered in the p21.3-p24 region of chromosome 3. Genomics (1996) 1.11
Production of bioactive amino-terminal domain of the thyrotropin receptor via insertion in the plasma membrane by a glycosylphosphatidylinositol anchor. FEBS Lett (1998) 1.11
Regional localization of the gene for thyroid peroxidase to human chromosome 2pter----p12. Cytogenet Cell Genet (1988) 1.10
Mapping thyroid peroxidase epitopes using recombinant protein fragments. Eur J Endocrinol (1995) 1.10
Chromosomal mapping of A1 and A2 adenosine receptors, VIP receptor, and a new subtype of serotonin receptor. Genomics (1991) 1.09
Translation of thyroglobulin 33S messenger RNA as a means of determining thyroglobulin quaternary structure. Proc Natl Acad Sci U S A (1975) 1.09
Distribution of adenosine A2 receptor mRNA in the human brain. Neurosci Lett (1991) 1.08
New insights into the pathophysiology of ovarian hyperstimulation syndrome. What makes the difference between spontaneous and iatrogenic syndrome? Hum Reprod (2004) 1.08
Natural proteolytic processing of hemofiltrate CC chemokine 1 generates a potent CC chemokine receptor (CCR)1 and CCR5 agonist with anti-HIV properties. J Exp Med (2000) 1.08
Familial congenital hypothyroidism due to inactivating mutation of the thyrotropin receptor causing profound hypoplasia of the thyroid gland. J Clin Invest (1997) 1.07
Autosomal dominant transmission of congenital thyroid hypoplasia due to loss-of-function mutation of PAX8. J Clin Endocrinol Metab (2001) 1.06
The thyrotropin receptor in thyroid eye disease. Thyroid (1998) 1.06
Thyroglobulin messenger RNA: translation of a 33-S mRNA into a peptide immunologically related to thyroglobulin. Eur J Biochem (1975) 1.06
Cloning and functional characterization of a human A1 adenosine receptor. Biochem Biophys Res Commun (1992) 1.06
Somatic and germline mutations of the TSH receptor gene in thyroid diseases. J Clin Endocrinol Metab (1995) 1.05
Structural and functional characterization of the two human ThOX/Duox genes and their 5'-flanking regions. Mol Cell Endocrinol (2004) 1.05
Thyroperoxidase, an auto-antigen with a mosaic structure made of nuclear and mitochondrial gene modules. EMBO J (1987) 1.05
Molecular cloning of a mouse melanocortin 5 receptor gene widely expressed in peripheral tissues. Biochemistry (1994) 1.05
Development of an animal model of autoimmune thyroid eye disease. J Immunol (1999) 1.05
A 3' splice site mutation in the thyroglobulin gene responsible for congenital goiter with hypothyroidism. J Clin Invest (1991) 1.04
Structure, tissue distribution, and chromosomal localization of the prepronociceptin gene. Proc Natl Acad Sci U S A (1996) 1.03
Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: implications for viral latency. J Virol (2001) 1.03
Differential effects of NaCl concentration on the constitutive activity of the thyrotropin and the luteinizing hormone/chorionic gonadotropin receptors. FEBS Lett (1996) 1.03
Control of thyroperoxidase and thyroglobulin transcription by cAMP: evidence for distinct regulatory mechanisms. Mol Endocrinol (1989) 1.02
Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia. J Clin Endocrinol Metab (1996) 1.02
Somatic and germline mutations of the TSH receptor and thyroid diseases. Clin Endocrinol (Oxf) (2001) 1.02
Current evidence for and against the TSH receptor being the common antigen in Graves' disease and thyroid associated ophthalmopathy. Clin Endocrinol (Oxf) (1995) 1.02
Muscle autoantigens in thyroid associated ophthalmopathy: the limits of molecular genetics. J Endocrinol Invest (1993) 1.02